Summary
Previously, extracellular vesicle production in Gram-positive bacteria
was dismissed due to the absence of an outer membrane, where Gram-negative
vesicles originate, and the difficulty in envisioning how such a process could
occur through the cell wall. However, recent work has shown that Gram-positive
bacteria produce extracellular vesicles and that the vesicles are biologically
active. In this study, we show that Bacillus subtilis produces
extracellular vesicles similar in size and morphology to other bacteria,
characterized vesicles using a variety of techniques, provide evidence that
these vesicles are actively produced by cells, show differences in vesicle
production between strains, and identified a mechanism for such differences
based on vesicle disruption. We found that in wild strains of B.
subtilis, surfactin disrupted vesicles while in laboratory strains
harboring a mutation in the gene sfp, vesicles accumulated in
the culture supernatant. Surfactin not only lysed B. subtilis
vesicles, but also vesicles from Bacillus anthracis, indicating
a mechanism that crossed species boundaries. To our knowledge, this is the first
time a gene and a mechanism has been identified in the active disruption of
extracellular vesicles and subsequent release of vesicular cargo in
Gram-positive bacteria. We also identify a new mechanism of action for
surfactin.
bCryptococcus neoformans produces extracellular vesicles containing a variety of cargo, including virulence factors. To become extracellular, these vesicles not only must be released from the plasma membrane but also must pass through the dense matrix of the cell wall. The greatest unknown in the area of fungal vesicles is the mechanism by which these vesicles are released to the extracellular space given the presence of the fungal cell wall. Here we used electron microscopy techniques to image the interactions of vesicles with the cell wall. Our goal was to define the ultrastructural morphology of the process to gain insights into the mechanisms involved. We describe single and multiple vesicle-leaving events, which we hypothesized were due to plasma membrane and multivesicular body vesicle origins, respectively. We further utilized melanized cells to "trap" vesicles and visualize those passing through the cell wall. Vesicle size differed depending on whether vesicles left the cytoplasm in single versus multiple release events. Furthermore, we analyzed different vesicle populations for vesicle dimensions and protein composition. Proteomic analysis tripled the number of proteins known to be associated with vesicles. Despite separation of vesicles into batches differing in size, we did not identify major differences in protein composition. In summary, our results indicate that vesicles are generated by more than one mechanism, that vesicles exit the cell by traversing the cell wall, and that vesicle populations exist as a continuum with regard to size and protein composition.
In this article, we present an overview of the different strategies for sample preparation for identification by mass spectrometry (MS) of biomarkers from serum and/or plasma. We consider the effects of the variables involved in sample collection, handling and storage, and describe different approaches for removal of high abundance proteins and serum/plasma fractionation. We review the advantages and disadvantages of such techniques as centrifugal ultrafiltration, different formats for solid phase extraction, organic solvent extraction, gel and capillary electrophoresis, and liquid chromatography. We also discuss a variety of current proteomic methods and their main applications for biomarker-related studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.